Royal Pharmaceutical Society (RPS) -
This policy document outlines how artificial intelligence (AI) can be used to support pharmacy practice and improve patient care. Developed in consultation with RPS members, Expert Advisory Group members, Board members, multi-professional experts in digital technology and AI, and external stakeholders including the General Pharmaceutical Council, the policy highlights the challenges and opportunities AI presents to enhance patient access, support clinical decisions and improve the safety and efficient of medicines supply chains.